Neuro
PrivateLast Round
VC Round
Mar 11, 2026
Total Funding Raised
$8.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuro operates in Consumer & Commerce and is based in Las Vegas, Nevada. Its latest recorded funding round was a VC Round in March 2026.
Neuro is a food products company that develops and sells functional chewing gum and mints infused with nootropics and vitamins to support energy, focus, calmness, and sleep.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Subscription Commerce
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuro Comparables
Compare Neuro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viter Energy | 89% | |
| REV GUM | 86% | |
| Dante Medical Solutions S.r.l. | 84% |
For institutional investors. Book with your work email.
Neuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 11, 2026 | ||||
| VC Round | Oct 16, 2024 | ||||
| Series A | Feb 8, 2023 | ||||
| Crowdfunding | Sep 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PM Equity Partner | Series A |
| BAM Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 31% MoM to 371.2K.
- May 4, 2026
Grew 15% QoQ, from 244 to 281 employees.
For institutional investors. Book with your work email.
Neuro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neuro's valuation, stock price, and market status.
Is Neuro a public or private company?
Neuro is a private company.
What is the current stock price of Neuro?
Neuro is a private company, so its shares have no public market price. Caplight tracks Neuro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuro worth (valuation)?
Valuation information for Neuro is not publicly available.
Can I buy Neuro stock?
Neuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuro's last funding round?
Neuro's most recent funding round was VC Round on March 11, 2026.
Who are the main investors in Neuro?
Key investors in Neuro include PM Equity Partner, BAM Ventures.
Will Neuro IPO soon?
No public IPO plans have been announced for Neuro.
How can I track Neuro secondary market activity?
Caplight tracks bids, offers, and trades in Neuro's shares on secondary markets.